A Tufts Center for the Study of Drug Development Impact Report says drug developers are making increasing use of artificial intelligence in a variety ...
FDA releases the FDA-483 with four observations from an inspection at Indias Torrent Pharmaceuticals.
Recros Medica files a de novo regulatory submission for the Nuvellus Focal Contouring System.
FDA releases its latest batch of Warning Letters that includes one medical product company Laboratoires Clarins.
FDA clears a Rapid Medical 510(k) for its Comaneci Temporary Coil Embolization Assist Device.
Federal Register notice: FDA announces a 6/20 Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee meeting.
FDA approves Pfizer subsidiary FoldRxs NDAs for Vyndaqel (tafamidis meglumine) and Vyndamax (tafamidis) capsules for treating heart disease caused by ...
Federal Register notice: FDA makes available a draft guidance entitled Attention Deficit Hyperactivity Disorder (ADHD): Developing Stimulant Drugs for...